Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

RaySearch Secures Distribution of RayStation® in Australia and New Zealand

Published: Thursday, March 20, 2014
Last Updated: Thursday, March 20, 2014
Bookmark and Share
Company has entered into an exclusive distribution agreement with AlphaXRT.

RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand.

The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch’s proprietary treatment planning system RayStation® in Australia and New Zealand from April 1, 2014.

Australasia is a well-established, world renowned and growing radiation therapy market. AlphaXRT is a leading distributor of software and equipment used in the treatment of cancer and represents a wide range of respected international suppliers.

The company was founded in 1990 and the dedicated sales and support team at AlphaXRT are highly experienced in the field of radiation therapy treatment planning systems and serve all radiation therapy centres in Australia and New Zealand.

“AlphaXRT is delighted to be representing RaySearch Laboratories in the treatment planning market in Australasia. RaySearch have a longstanding reputation in treatment planning solutions and RayStation® is the leading independent treatment planning system available. We look forward to working with RaySearch to promote RayStation® to our customers in the region”, says Richard Neale, Managing Director of AlphaXRT.

“AlphaXRT is a leading distributor of advanced radiation therapy equipment with a long track record, so we are of course delighted that they have elected to partner with RaySearch. We will now work closely together with AlphaXRT’s experienced experts to satisfy the needs of existing and future RayStation® customers and I am fully convinced that this collaboration will be highly fruitful for both companies”, says Johan Löf, CEO of RaySearch.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Ghent University Hospital Chooses RayStation as Main Treatment Planning System
Company has announced that the UZ Gent has selected RayStation® to streamline its planning workflow in a multivendor linac setup.
Saturday, March 12, 2016
Scientific News
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Interpreting “Dark Matter” DNA
Scientists at the Gladstone Institutes have invented a new way to read and interpret the human genome.
A Programming Language for Living Cells
New language lets researchers design novel biological circuits.
The Epigenetics of Childhood Cancer
Qlucore software enables researchers to more easily study the genetic influences behind childhood cancer.
Mining Whole Exome Data to Improve Cancer Therapies
New tool interprets the raw data of whole exome tumor sequencing and then matches the cancer’s unique genetics to FDA-approved targeted treatments.
Pittcon 2016: Accelerating Innovation And Enhancing Productivity With Technology
Collaboration and externalization of data highlight evolving lab operations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!